HCmed Innovations CoTPE:6934 -2.16%11 PB Ratio is 7.74 as of Jul. 07, 2026, which is 11% below its 10-year median of 8.73. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 87.18% on this metric.
The historical rank and industry rank for HCmed Innovations Co's PB Ratio or its related term are showing as below:
TPE:6934'
s PB Ratio Range Over the Past 10 Years
Min: 6.79 Med: 8.73 Max: 17.42
Current: 7.74
During the past 5 years, HCmed Innovations Co's highest PB Ratio was 17.42. The lowest was 6.79. And the median was 8.73.
TPE:6934's PB Ratio is ranked worse than 87.18% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs TPE:6934: 7.74
During the past 12 months, HCmed Innovations Co's average Book Value Per Share Growth Rate was 26.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of HCmed Innovations Co was 13.60% per year. The lowest was 13.60% per year. And the median was 13.60% per year.
Back to Basics: PB Ratio
HCmed Innovations Co (TPE:6934) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
HCmed Innovations Co PB Ratio Related Terms
HCmed Innovations Co PB Ratio Historical Data
* Premium members only.
The historical data trend for HCmed Innovations Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, HCmed Innovations Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCmed Innovations Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where HCmed Innovations Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
HCmed Innovations Co (TPE:6934) has a PB Ratio of 7.74 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on HCmed Innovations Co and its competitors. This is 11% below median its historical median of 8.73. Over the past decade, HCmed Innovations Co's PB Ratio has ranged from 6.79 to 17.42. According to the industry distribution chart, HCmed Innovations Co ranks #687 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 87.2%.
Is HCmed Innovations Co's PB Ratio too high?
HCmed Innovations Co's current PB Ratio of 7.74 is 11% below median its 10-year median of 8.73. Over the past 10 years, this metric has ranged from a low of 6.79 to a high of 17.42. The Medical Devices & Instruments industry median PB Ratio is 2.07. HCmed Innovations Co's value of 7.74 is 274.8% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #687 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #687 out of 788 companies for PB Ratio. This places HCmed Innovations Co in the lower half of its industry. The industry median PB Ratio is 2.07. HCmed Innovations Co's value of 7.74 is 274.8% above this benchmark. Historically, HCmed Innovations Co's own PB Ratio has ranged from 6.79 to 17.42 over the past decade. While the company's 10-year median is 8.73 vs. the industry median of 2.07, HCmed Innovations Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current PB Ratio of 7.74 is 274.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current PB Ratio is 7.74, which is 11% below median its own 10-year median of 8.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current PB Ratio of 7.74. The current PB Ratio is 7.74, which is 11% below median its 10-year median of 8.73 and 274.8% above the Medical Devices & Instruments industry median of 2.07. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current PB Ratio is 7.74 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score
Get the complete analysis for TPE:6934
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6934 has been successfully added to your 
